Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
top of page Home About Inside ED HRT Intravenous Therapy Performance Peptides Sexual Dysfunction Weight Loss Outside Anti-Aging Lash Spa Aesthetics Neurotoxins Juvederm Laser & Lights Cosmeceuticals Hair Loss Solutions How to Videos Required Forms Online Store More Use tab to navigate through the menu items
The absence of preservatives means sterile water lacks antimicrobial protection once the vial is opened
InfiniWell BPC-157 500 mcg Pro Delayed Release Ingredients: InfiniWell BPC-157 500 mcg Pro Delayed Release Ingredients: Serving Size: 1 Capsule Body Protective Compound (as BPC-157 Arginate Salt) 500 mcg Salcaprozate Sodium (SNAC) 3 mg Other Ingredients: Rice Powder, Microcrystalline Cellulose, Vegetable Capsule (Hypromellose, Gellan Gum) Delayed-Release Capsules, Gluten Free, Dairy Free, Soy Free, Non-GMO Warnings: If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.
US$ 21.14
US$ 23.36
US$ 26.15
US$ 23.14
US$ 28.87
US$ 27.01
